Prostate cancer statistics

Cases

New cases of prostate cancer, 2012, UK

Deaths

Deaths from prostate cancer, 2012, UK

Survival

Survive prostate cancer for 10 or more years, 2010-11, England and Wales

Prevention

Preventable cases of prostate cancer are not known as it is not clearly linked to any preventable risk factors

  • There were around 43,400 new cases of prostate cancer in the UK in 2012, that’s around 119 men every day.
  • Prostate cancer is the third most common cancer in the UK (2012).
  • Prostate cancer accounts for 13% of all new cases in the UK (2012).
  • Prostate cancer is the most common cancer in the UK, with around 43,400 cases diagnosed in 2012.
  • More than a third (36%) of prostate cancer cases are diagnosed in men aged over 75 years.
  • Since the late-1970s, prostate cancer incidence rates have more than doubled (147% increase) in Great Britain, although much of the increase is due to increased detection through widespread use of the PSA test.
  • Over the last decade, prostate cancer incidence rates have increased by less than a tenth (5%) in the UK.
  • In Europe, around 417,000 new cases of prostate cancer were estimated to have been diagnosed in 2012. The UK incidence rate is 17th highest in Europe.
  • Worldwide, more than 1.11 million men were estimated to have been diagnosed with prostate cancer in 2012, with incidence rates varying across the world.
  • 1 in 8 men will be diagnosed with prostate cancer during their lifetime.

Read more in-depth prostate cancer incidence statistics

  • Prostate cancer is the second most common cause of cancer death in UK men, after lung cancer.
  • In 2012 in the UK around 10,800 men died from prostate cancer, that's 30 every day.
  • Almost three quarters of prostate cancer deaths occur in men aged 75 and over.
  • Prostate cancer death rates peaked in the early 1990s and have since fallen by around a fifth.
  • In Europe, around 92,300 men were estimated to have died from prostate cancer in 2012. The UK mortality rate is 15th highest in Europe.
  • Worldwide, more than 307,000 men were estimated to have died from prostate cancer in 2012, with mortality rates varying across the world.

Read more in-depth prostate cancer mortality statistics

  • More than 8 in 10 (84%) men diagnosed with prostate cancer in England and Wales survive their disease for ten years or more (2010-11).
  • Almost 9 in 10 (85%) men diagnosed with prostate cancer in England and Wales survive their disease for five years or more (2010-11).
  • Almost 95% (94%) of men diagnosed with prostate cancer in England and Wales survive their disease for one year or more (2010-11).
  • Prostate cancer survival is highest for men diagnosed aged 50-69 years old, probably because of PSA testing.
  • More than 9 in 10 men diagnosed aged 50-69 survive their disease for five years or more, compared with around 6 in 10 men diagnosed aged 80 and over.
  • Prostate cancer survival is improving and has tripled in the last 40 years in the UK, probably because of PSA testing.
  • In the 1970s, a quarter of men diagnosed with prostate cancer survived their disease beyond ten years, now it's more than 8 in 10.
  • When diagnosed at its earliest stage, all men with prostate cancer will survive their disease for five years or more, compared with less than a third of men when diagnosed at the latest stage.

Read more in-depth prostate cancer survival statistics

  • Prostate cancer is not clearly linked to any preventable risk factors.
  • A man’s risk of developing prostate cancer depends on many factors, including age,genetics, and possibly exposure to risk factors.
  • No modifiable factors have been conclusively linked with prostate cancer risk, though many factors have been studied. Use of PSA testing often makes interpretation of evidence difficult.
  • Some factors may relate to higher prostate cancer risk, including certain occupational exposures, ionising radiation, and certain medical conditions, but evidence is unclear.
  • Some foods and supplements may relate to lower prostate cancer risk, but evidence is unclear.

Read more in-depth prostate cancer risk factors

  • GP referral (not ‘two-week wait’) is the most common route to diagnosis of prostate cancer.
  • ‘Two-week wait’ standards are met by all countries, ‘31-day wait’ and ‘62-day wait’ are not met by any country for urological cancers.
  • Almost a tenth of prostate cancer patients receive major surgical resection as part of their cancer treatment.
  • Almost 9 in 10 patients had a ‘very good’ or ‘excellent’ patient experience.
  • More than 8 in 10 patients are given the name of their Clinical Nurse Specialist.

Want these Key Stats as a document or looking for a stats report?
Use the print function at the bottom of any page Share this page > +Other > Print or through your browser options to print or save these stats.

The latest statistics available for prostate cancer in the UK are; incidence 2012, mortality 2012 and survival 2010-2011.

The ICD code Open a glossary item for prostate cancer is ICD-10 C61.

European Age-Standardised Rates were calculated using the 1976 European Standard Population (ESP) unless otherwise stated as calculated with ESP2013. ASRs calculated with ESP2013 are not comparable with ASRs calculated with ESP1976.

Lifetime risk estimates were calculated using incidence, mortality, population and all-cause mortality data for 2012.

Survival statistics give an overall picture of survival and (unless otherwise stated) include all adults (15-99) diagnosed, at all ages, stages Open a glossary item and co-morbidities Open a glossary item. The survival time experienced by an individual patient may be much higher or lower, depending on specific patient and tumour characteristics.

Stage at diagnosis data is not yet routinely available for the UK due to inconsistencies in the collecting and recording of staging data in the past.

Meta-analyses Open a glossary item and systematic reviews Open a glossary item are cited on this page where available, as they provide the best overview of all available research and most take study quality into account. Individual case-control and cohort studies Open a glossary item are reported where such aggregated data are lacking.

Routes to diagnosis statistics were calculated from cases of cancer registered in England which were diagnosed in 2006-2010.

Cancer waiting times statistics are for patients who entered the health care system within financial year 2014-15. Prostate cancer is part of the group 'Urological cancer' for cancer waiting times data. Codes vary per country but broadly include: penis, prostate, testis, other and unspecified male genital organs, kidney, renal pelvis, ureter, bladder, other and unspecified urinary organs, secondary cancers of kidney, renal pelvis, bladder and other unspecified urinary organs.

Cancer surgical resection rates data is for patients diagnosed in England between 2006 and 2010.

Patient Experience data is for adult patients in England with a primary diagnosis of cancer, who were in active treatment between September and November 2013 and who completed a survey in 2014.

Citation

You are welcome to reuse this Cancer Research UK statistics content for your own work.

Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year]. 

Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK. 

Acknowledgements

We would like to acknowledge the essential work of the cancer registries in the United Kingdom and Ireland Association of Cancer Registries, without which there would be no data.

Rate this page:

Currently rated: 4.4 out of 5 based on 16 votes
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page